How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for how individual genetic predispositions in GLP-1 and GIP receptor pathways (variants like GIPR rs1800437) could relate to baseline metabolism and peptide responsiveness
Researchers are investigating other novel combinations, like the GLP-1/Glucagon dual-agonist Survodutide, to explore which specific receptor combinations yield the best outcomes for different metabolic profiles
Anonymous Patient, 29 I was embarrassed about my double chin and tired of being told to just walk more. This protocol felt modern, medical, and made for someone like me. Patient C, 43 Unlike conventional diet plans or gym-only programs, medical weight loss treatment targets the hormonal and metabolic drivers of weight gain, including insulin resistance and appetite dysregulation
The interaction of GLP-1 and GLP-1RAs with GLP-1Rs of the brain includes various molecular and cellular mechanisms that are the basis for translation into the clinic, since these mechanisms counteract many key links in the pathogenesis of brain diseases
Small Extracell vesicles breast cancer cells induce cardiotoxicity
Technological Advancements in Drug Formulation: Advancements in drug formulation technology have enhanced the efficacy and convenience of GLP-1 receptor agonists